Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

RegMed Daily, Closing Bell, 11/4/11, markets will continue to ebb and flow on EU news

End of Day, Cause and Effect …

 

EU sovereign debt developments are expected to command investor attention (stealing attention from our RegMed Universe), next week as earnings season continue and a light offering of economic data is served up. But the uncertainty was enough to break a string of weekly gains for US stocks.

The market will be hard pressed until a deal is solidified. If one comes shortly, then expect a lightning strike uthe indexes. Unfortunately, if the deal fritters away, then don’t be surprised with a ride back down …

Closing Bell: The NASDAQ closed DOWN -81.82 (-0.44%) to 2,686.15. The Dow closed DOWN -61.23 (-0.51%) to 11,893.24.

Who’s up … at the close and any … whys:   Athersys (NASDAQ:ATHX) +$0.01 <0.39%> to 1.41; Dendreon (NASDAQ:DNDN) +0.14<+2.12%> to $6.69;Geron (NASDAQ:GERN) +$0.02 <0.85%> to $2.38; ReNeuron (RENE.LON) +$0.18 <+4.14%> to $4.40; Tengion (TNGN) +$0.003 <0.60%> to +$0.52 and ThermoGenesis (NASDAQ:KOOL) +$0.02 <1.67%> to $1.22

**<Small/Moderate Volumes>